Previous Close | 1.7000 |
Open | 1.6700 |
Bid | 1.7000 |
Ask | 4.6000 |
Strike | 7.50 |
Expire Date | 2024-05-17 |
Day's Range | 1.6700 - 1.7000 |
Contract Range | N/A |
Volume | |
Open Interest | 22 |
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2024.
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024 at 2:30 p.m. ET in Toronto, Canada.